First CGRP Blocker Approved for Kids’ Migraine Prevention

By News Health
3 weeks Ago

(MedPage Today) — The FDA expanded the indication for fremanezumab (Ajovy) injection for episodic migraine prevention to include children and adolescents, Teva Pharmaceuticals announced.
Fremanezumab can now be used to treat kids ages 6 to 17…

Source link : https://www.medpagetoday.com/neurology/migraines/116885

Author :

Publish date : 2025-08-07 18:49:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

High-Dose Flu Shot May Cut Some Hospitalizations in Older Adults

'Slimming jabs have changed the way we do things'

Novel Oral Agent Proves Mettle in Obstructive Hypertrophic Cardiomyopathy

State Laws on Unilateral Decisions for Life Support Are All Over the Map

Getting a COVID Shot Just Became Much More Difficult. Here's Why.

'Weekend Warriors' See Lower Gout Risk, Similar to Gym Rats